Study to Reveal if Fibrinogen Treatment Effects Blood Clotting Better Than a Platelet Transfusion

PHASE4CompletedINTERVENTIONAL
Enrollment

130

Participants

Timeline

Start Date

December 31, 2012

Primary Completion Date

August 31, 2014

Study Completion Date

August 31, 2014

Conditions
Blood Platelet TransfusionBlood Clotting
Interventions
DRUG

Administration of platelet concentrate and taking blood samples

Patient with the need of a platelet transfusion, will have 4 intervention points. 1. directly before the start of the transfusion a blood sample will be drawn. 2. Patient receives the platelet transfusion. 3. One hour after the end of transfusion a second blood sample will be drawn. 4. 24 h after the end of the platelet transfusion a further bloos sample will be collected. The first two samples will be (beside blood cell counts) spiked in-vitro with different amounts of Human fibrinogen and blood clotting tests will be performed. The same with the 3. blood sample, but without spiking steps.

Trial Locations (5)

6020

Central Institution for Blood Transfution and Immunology, Innsbruck

Department for Anesthesia and Intensive Care Medicine, Innsbruck

General and Surgical Intensive Care Medicine, Innsbruck

8200

Faculty of Health Sciences, Centre for Haemophilia and Thrombosis, Aarhus University Hospital, Aarhus

Faculty of Health Sciences, Department for Anaesthesia and Critical Care Medicine, Aarhus

All Listed Sponsors
lead

Medical University Innsbruck

OTHER

NCT01955811 - Study to Reveal if Fibrinogen Treatment Effects Blood Clotting Better Than a Platelet Transfusion | Biotech Hunter | Biotech Hunter